Stephens & Co. analyst Sudan Loganathan initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight rating and announces Price Target of $51.
- Headlines
- Stephens & Co. Initiates Coverage On IDEAYA Biosciences With Overweight Rating, Announces Price Target of $51
Stephens & Co. Initiates Coverage On IDEAYA Biosciences With Overweight Rating, Announces Price Target of $51
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
23:00
In 2024, Russia's oil revenue contribution to the national budget will grow by nearly one-third, reaching the highest contribution level since 2018.
22:58
Mercedes-Benz will launch the CLA model equipped with Google's AI assistant this year.
MBGYY+1.14%
22:58
United States Steel stock rose by 7.7%. In the news, CLEVELAND-CLIFFS and NUCOR are collaborating on a potential bid for United States Steel, with a Quote expected to be over $30 per share.
X+8.79%